Related references
Note: Only part of the references are listed.Role of the A chain in thrombin function
M. E. Papaconstantinou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Activated protein C in sepsis: a critical review
Marcel Levi
CURRENT OPINION IN HEMATOLOGY (2008)
Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
Shona Harmon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions
Laurent O. Mosnier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Endotoxemia and sepsis mortality reduction by non-anticoagulant-activated protein C
Edward J. Kerschen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1
Likui Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The advent of the cytokine storm
Ian A. Clark
IMMUNOLOGY AND CELL BIOLOGY (2007)
Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment
G. F. Pierce et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties
Jong-Sup Bae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis
S. Konstantinides et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities
Laurent O. Mosnier et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Two-way interactions between inflammation and coagulation
M Levi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
The promise and challenges of bioengineered recombinant clotting factors
SW Pipe
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Regulation of blood coagulation by the protein C anticoagulant pathway -: Novel insights into structure-function relationships and molecular recognition
B Dahlbäck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Activated protein C mediates novel lung endothelial barrier enhancement - Role of sphingosine 1-phosphate receptor transactivation
JH Finigan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation
C Feistritzer et al.
BLOOD (2005)
Activated protein C variants with normal cytoprotective but reduced anticoagulant activity
LO Mosnier et al.
BLOOD (2004)
Extended evaluation of recombinant human activated protein C United States trial (ENHANCE US) - A single-arm, phase 313, multicenter study of drotrecogin alfa (activated) in severe sepsis
GR Bernard et al.
CHEST (2004)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
E Abraham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor
LO Mosnier et al.
BIOCHEMICAL JOURNAL (2003)
Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model
JA Fernández et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
GR Bernard et al.
CRITICAL CARE (2003)
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
T Cheng et al.
NATURE MEDICINE (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C
AJ Gale et al.
PROTEIN SCIENCE (2002)
Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C
AJ Gale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The crystal structure of the endothelial protein C receptor and a bound phospholipid
V Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of endothelial cell protease activated receptor 1 by the protein C pathway
M Riewald et al.
SCIENCE (2002)
High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
BL Warren et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis
DE Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)